ENG/中
老虎证券
市场
行情
24/7新闻
产品
Cash Boost账户
期权
A股通
港股
固定票息票据
美股
ETF
基金超市
美国国债
新加坡股
期货
Tiger BOSS Debit Card
老虎钱袋子
功能
经纪人
定投
CPF/SRS 投资
专栏
美股碎股
TigerAI
费用
综合账户
股票与ETF
期权、窝轮与牛熊证
期货
债券
基金超市
Cash Boost
股票与ETF
融资利率
活动
帮助
账户操作
如何开户
开户文件
账户类型
资金与转仓
入金
DDA快捷入金
出金
转入股票
转出股票
货币兑换
产品与交易
可交易产品
订单类型
交易规则
申报
融资融券
保证金与杠杆
风险管理
做空风险
基金超市
基金开户与交易
Cash Boost账户
Cash Boost 账户FAQ
如何开通 Cash Boost 账户
如何用Cash Boost 账户交易
如何绑定CDP证券账户
Tiger Boss Debit Card
常见问题
费用说明
如何充值
如何使用我的Debit card
账单报表
账单报表
股息(分红)
机构
Tiger Fund Management
机构服务
财富及资产管理人
自营交易机构
介绍经纪商
三方服务商
老虎API平台
登录
立即注册
Toggle
美股
详情
本页面由Tiger Trade Technology Pte. Ltd.提供服务
Novo Nordisk A/S B Shares ADRhedged
21.79
+0.1169
0.54%
盘后:
21.79
0.0000
0.00%
16:04 EDT
成交量:
65
成交额:
1,413
市值:
370.38万
市盈率:
- -
高:
21.79
开:
21.67
低:
21.79
收:
21.67
52周最高:
34.36
52周最低:
19.00
股本:
17.00万
流通股本:
17.00万
量比:
0.03
换手率:
0.04%
股息:
1.56
股息率:
7.16%
净资产收益率:
--
总资产收益率:
--
市净率:
--
市盈率(LYR):
- -
数据加载中...
总览
公司
新闻资讯
公告
概念
没有相关数据
资金流向
资金流入:
资金流出:
实时
日
周
月
季度
年
新闻资讯
国产减肥药公布积极研究数据,GLP-1药物进入长效竞争?
澎湃新闻
·
昨天
减肥药还能抗衰老?第一款大众抗衰药可能正在路上
麻省理工科技评论
·
10/08
Zealand Pharma与罗氏在研减肥药中期临床试验帮助患者减重高达9.2%
格隆汇
·
10/08
GLP-1减重药市场前景广阔 世卫组织对青少年用药设置严格适用条件
金吾财讯
·
10/07
{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hans/stock/NVOH"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"NVOH","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NVOH\",,,,,undefined,":{"symbol":"NVOH","market":"US","secType":"STK","nameCN":"Novo Nordisk A/S B Shares ADRhedged","latestPrice":21.7869,"timestamp":1791576000000,"preClose":21.67,"halted":0,"volume":65,"hourTrading":{"tag":"盘后","latestPrice":21.7869,"preClose":21.7869,"latestTime":"16:04 EDT","volume":2,"amount":43.5738,"timestamp":1791576245583,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0.005394554683894673,"floatShares":170001,"shares":170001,"eps":0,"marketStatus":"盘后交易","change":0.1169,"latestTime":"10-09 17:45:23 EDT","open":21.67,"high":21.7869,"low":21.7869,"amount":1413,"amplitude":0,"askPrice":29.3,"askSize":100,"bidPrice":18.27,"bidSize":100,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1791590400000},"marketStatusCode":4,"adr":0,"exchange":"ARCA","adjPreClose":21.67,"nav":21.635165,"aum":3677999.685165,"dividendRate":0.071607,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":21.7869,"preClose":21.7869,"latestTime":"16:04 EDT","volume":2,"amount":43.5738,"timestamp":1791576245583,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.029041,"impliedVol":0.485,"impliedVolPercentile":0.9248},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NVOH\",,,,,undefined,":{"symbol":"NVOH","floatShares":170001,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.029041,"shares":170001,"dividePrice":1.5601,"high":21.7869,"amplitude":0,"preClose":21.67,"low":21.7869,"week52Low":19,"pbRate":"--","week52High":34.36,"institutionHeld":0,"latestPrice":21.7869,"eps":0,"divideRate":0.071607,"volume":65,"delay":0,"ttmEps":0,"open":21.67,"prevYearClose":27.4362,"prevWeekClose":20.9938,"prevMonthClose":21.2125,"prevQuarterClose":21.2125,"fiveDayClose":20.9938,"twentyDayClose":23.4261,"sixtyDayClose":27.8996},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/NVOH\",params:#limit:5,,,undefined,":[{"date":"2026-09-16","symbol":"NVOH","amount":0.02979,"announcedDate":"2026-09-15","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-09-16","defaultRemindTime":1789565400000,"name":"Novo Nordisk A/S B Shares ADRhedged","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-09-23","payableDate":"2026-09-16","currency":"USD","dateTimestamp":1789531200000,"payDate":"2026-09-23"},{"date":"2026-06-16","symbol":"NVOH","amount":0.76666,"announcedDate":"2026-06-15","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-16","defaultRemindTime":1781616600000,"name":"Novo Nordisk A/S B Shares ADRhedged","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-23","payableDate":"2026-06-16","currency":"USD","dateTimestamp":1781582400000,"payDate":"2026-06-23"},{"date":"2026-03-16","symbol":"NVOH","amount":0.27495,"announcedDate":"2026-03-13","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-03-16","defaultRemindTime":1773667800000,"name":"Novo Nordisk A/S B Shares ADRhedged","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-23","payableDate":"2026-03-16","currency":"USD","dateTimestamp":1773633600000,"payDate":"2026-03-23"},{"date":"2025-12-16","symbol":"NVOH","amount":0.48798,"announcedDate":"2025-12-15","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-16","defaultRemindTime":1765895400000,"name":"Novo Nordisk A/S B Shares ADRhedged","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-24","payableDate":"2025-12-16","currency":"USD","dateTimestamp":1765861200000,"payDate":"2025-12-24"},{"date":"2025-09-16","symbol":"NVOH","amount":0.16566,"announcedDate":"2025-09-15","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-16","defaultRemindTime":1758029400000,"name":"Novo Nordisk A/S (B Shares) ADRhedged","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-23","payableDate":"2025-09-16","currency":"USD","dateTimestamp":1757995200000,"payDate":"2025-09-23"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"NVOH\",market:\"US\",,,undefined,":[{"executeDate":"2025-09-16","recordDate":"2025-09-16","paymentDate":"2025-09-23","value":0.16566,"currency":"USD"},{"executeDate":"2025-12-16","recordDate":"2025-12-16","paymentDate":"2025-12-24","value":0.48798,"currency":"USD"},{"executeDate":"2026-03-16","recordDate":"2026-03-16","paymentDate":"2026-03-23","value":0.27495,"currency":"USD"},{"executeDate":"2026-06-16","recordDate":"2026-06-16","paymentDate":"2026-06-23","value":0.76666,"currency":"USD"},{"executeDate":"2026-09-16","recordDate":"2026-09-16","paymentDate":"2026-09-23","value":0.02979,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"NVOH\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"NVOH\",pageSize:4,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2674571328","title":"国产减肥药公布积极研究数据,GLP-1药物进入长效竞争?","url":"https://stock-news.laohu8.com/highlight/detail?id=2674571328","media":"澎湃新闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674571328?lang=zh_cn&edition=fundamental","pubTime":"2026-10-09 21:41","pubTimestamp":1791553260,"startTime":"0","endTime":"0","summary":"10月9日,广东众生药业股份有限公司(众生药业,002317)10%涨停。消息面上,10月8日晚间,众生药业发布公告称,控股子公司广东众生睿创生物科技有限公司(简称“众生睿创”)自主研发的一类创新多肽药物RAY1225注射液在超重或肥胖参与者的安全性和有效性的多中心、随机、双盲、安慰剂对照的三期临床试验,于近日获得顶线分析数据。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202610093891510724.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202610093891510724.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["XLVI","NVOC","TRUH","THNR","PJP","JDOC","FHLC","CURE","MEDI","RSPH","IYH","PINK","NVOH","FXH","NBDS","NVOX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673891024","title":"减肥药还能抗衰老?第一款大众抗衰药可能正在路上","url":"https://stock-news.laohu8.com/highlight/detail?id=2673891024","media":"麻省理工科技评论","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673891024?lang=zh_cn&edition=fundamental","pubTime":"2026-10-08 15:36","pubTimestamp":1791444960,"startTime":"0","endTime":"0","summary":"热门减肥药可能不只可以帮助人们减掉体重,还可能让岁月的痕迹一同消退。他被认为是“衰老时钟”的发明者之一。它们能够改善肾功能、降低血压,甚至显著降低总体死亡风险。诺和诺德发现,随着时间推移,这些药物能够让多种衰老时钟显示出衰老减缓的迹象。多位与会者提醒,GLP-1 类药物确实存在副作用,其中包括肌肉流失。与此同时,该项目还希望帮助建立针对抗衰老药物的监管路径,并围绕长寿领域“建立一个新的治疗产业”。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://tech.ifeng.com/c/8x3ZZsOsIiW","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"fenghuang_stock","symbols":["IYH","PINK","TRUH","CURE","NVOX","MEDI","NVOH","FXH","PJP","NBDS","XLVI","RSPH","NVOC","FHLC","THNR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673808042","title":"Zealand Pharma与罗氏在研减肥药中期临床试验帮助患者减重高达9.2%","url":"https://stock-news.laohu8.com/highlight/detail?id=2673808042","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673808042?lang=zh_cn&edition=fundamental","pubTime":"2026-10-08 10:37","pubTimestamp":1791427037,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BMED","MDTX","PJP","TRUH","IBBJ","NVOH","NVOX","RSPH","PSYK","MEDI","THNR","FXH","NVOC","PINK","FHLC","XLVI","NBDS","CURE","IBBQ","IYH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673090680","title":"GLP-1减重药市场前景广阔 世卫组织对青少年用药设置严格适用条件","url":"https://stock-news.laohu8.com/highlight/detail?id=2673090680","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673090680?lang=zh_cn&edition=fundamental","pubTime":"2026-10-07 19:34","pubTimestamp":1791372848,"startTime":"0","endTime":"0","summary":"当前热门的GLP-1类减重药物包括诺和诺德Wegovy、礼来Zepbound,华尔街机构预测该赛道2030年最高年销售额可达1000亿美元。监管层面,Zepbound仅获批用于18岁以上成人;Wegovy在美国已获批拓展至12岁及以上青少年。","market":"hk","thumbnail":"https://static.szfiu.com/news/20250107/ZmY2NTQyNTc0MzU2NTg=.png","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250107/ZmY2NTQyNTc0MzU2NTg=.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"299f0a9977df499f8ead781071e5e5e7","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"306929","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2237443622.USD","SGXZ81514606.USD","LU0097036916.USD","LU0198837287.USD","LU2089984988.USD","LU2265009873.SGD","LU1868836914.USD","LU2746668974.SGD","OZEM","BK4534","LU0316494557.USD","LU2089284900.SGD","LU2112291526.USD","LU0096364046.USD","LU0354030511.USD","LU2491050154.USD","LU0323591593.USD","LU2461242641.AUD","CANC","LU0094547139.USD","LU0210536198.USD","LU2023250330.USD","SGXZ31699556.SGD","VHT","BK4585","LU0823434583.USD","LU1712237335.SGD","NVOC","IE00BJLML261.HKD","LU2237443465.HKD","LU1232071149.USD","SG9999018857.SGD","TMED","LU2168564149.EUR","MEDX","SG9999017495.SGD","LU0106261372.USD","PJP","LU0061475181.USD","BK4532","LU0385154629.USD","LU2471134523.USD","LU2746668461.USD","IE0004445239.USD","LU1868836591.USD","LU1145028129.USD","BK4516","NVOX","LU1291159041.SGD","LU1323610961.USD","LU2023251221.USD","BK4533","TRUH","LU0432979614.USD","LU0158827781.USD","LU1548497426.USD","LU2106854487.HKD","PPH","SG9999015945.SGD","LU1035775433.USD","ELIS","LLII","IE0005OL40V9.USD","LLY","IE00B7KXQ091.USD","LU1720051108.HKD","LU1093756325.SGD","BK4007","LU1093756168.USD","LU2552382058.USD","LU1804176565.USD","MEDI","LU2756315318.SGD","SG9999013999.USD","LU2361044949.HKD","LU0256863902.USD","LU2552382215.SGD","IE0004445015.USD","LU0471298777.SGD","IXJ","LU0345770993.USD","SG9999015986.USD","LU1814569148.SGD","IE0009355771.USD","LU0823416689.USD","LU2023250504.SGD","IE00BFSS7M15.SGD","LU2324357040.USD","LU0820562030.AUD","LU2089283258.USD","LU0320765059.SGD","LU1974910355.USD","LU2491049909.HKD","LU1069344957.HKD","LU2087625088.SGD","LU2361044865.SGD","SGXZ57979304.SGD","LU0889565916.HKD","IE00B1XK9C88.USD","LU2361045086.USD","LU2750360997.AUD","LU2213496289.HKD","SGXZ51526630.SGD","IE00BJJMRY28.SGD","GB00BDT5M118.USD","SG9999014914.USD","LU0689472784.USD","LU2063271972.USD","LU0345770308.USD","LU0964807845.USD","LU2237438978.USD","LU0133085943.USD","IE00B4R5TH58.HKD","LU0225283273.USD","LU0174119429.USD","LU1868837300.USD","LU0006306889.USD","GDOC","IE00BZ1G4Q59.USD","LU2602419157.SGD","IE00B1BXHZ80.USD","LU0256863811.USD","LLYZ","AGNG","LU0466842654.USD","LU0203202063.USD","IYH","IE0001KFT4U8.USD","IE00BK4W5M84.HKD","LU2168564495.EUR","NVOH","LU2237443549.SGD","LU2111349929.HKD","LU2417539215.USD","LU2456880835.USD","LU2896262040.SGD","LU2491050071.SGD","IE00BJJMRZ35.SGD","CURE","LU2236285917.USD","LU0456855351.SGD","LU1551013342.USD","LU2237443382.USD","BK4588","LU0683600562.USD","LU1989771016.USD","SG9999014880.SGD","LU1280957306.USD","FHLC","IE00BJT1NW94.SGD","IE00BKDWB100.SGD","LU0234572021.USD","LU1720051017.SGD","LU0158827948.USD","IE00BJJMRX11.SGD","LU2028103732.USD","LU0238689110.USD","FTXH","LU0354030438.USD","LU0823434740.USD","LU2271345857.HKD","IE00B4JS1V06.HKD","LU0289739699.SGD","LU2750360641.GBP","LU0320765992.SGD","LU2756315664.SGD","SG9999018865.SGD","LU2471134952.CNY","LU0353189680.USD","SG9999001176.USD","SG9999014906.USD","LLYX","LU0708995401.HKD","LU0672654240.SGD","IE00BFSS8Q28.SGD","LU0943347566.SGD","LU2211815571.USD","LU2237443895.HKD","LU2237443978.SGD","LU2360106947.USD","BK4599","LU2552382132.HKD","LU1061106388.HKD","RXL","SG9999001176.SGD","SGXZ99366536.SGD","LU2471134796.USD","LU0122379950.USD","SG9999014898.SGD","LU1064131342.USD","IE00BN29S564.USD","LU2168564222.USD","LU1868836757.USD","LU0882574139.USD","LU1127390331.HKD","LU0471298694.HKD","IE00BWXC8680.SGD","LU2471134879.HKD","LU2357305700.SGD","IE00BKVL7J92.USD","LU0820561909.HKD","LU0109391861.USD","IHE","HRTS","LU0203201768.USD","BK4581","IE00BKPKM429.USD","LU0109394709.USD","LU1988902786.USD","LU1551013425.SGD","IE00BK4W5L77.USD","LU2108987350.USD","LU2462157665.USD","LU0820561818.USD","LU2168564065.EUR","LU2468319806.SGD","MHIP","XLV","ELIL","LU0079474960.USD","LU1983299246.USD","LU2168563687.JPY","LU1868837136.USD","LU0266013472.USD","LU1267930730.SGD","LU1623119135.USD","LU0353189763.USD","NVO","LU1057294990.SGD","LU0417517546.SGD","SG9999015952.SGD","LU0640476718.USD","IE00BFTCPJ56.SGD","SG9999015978.USD","THNR","LU1979441026.SGD","LU0787776722.HKD","LU1366192091.USD","LU1629891620.HKD","LU2462591350.SGD","WDNA","IE0002141913.USD","LU0882574055.USD","LU2264538146.SGD","IE00B775H168.HKD","LU0154236417.USD","LU0058720904.USD","LU0114720955.EUR","LU1023059063.AUD","LU0786609619.USD","IE00B2B36J28.USD","ILDR","LU1691799644.USD","LU1917777945.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":50,"pageCount":1,"totalSize":200,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/NVOH\",params:#limit:6,delay:false,,,undefined,":[]}}